• This record comes from PubMed

Facilitated Data Relay and Effects on Treatment of Severe Aortic Stenosis in Europe

. 2019 Oct ; 8 (19) : e013160. [epub] 20190924

Language English Country Great Britain, England Media print-electronic

Document type Comparative Study, Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/pmid31549578

Background Many patients with severe aortic stenosis are referred late with advanced symptoms or inappropriately denied intervention. The objective was to investigate whether a structured communication to referring physicians (facilitated data relay) might improve the rate and timeliness of intervention. Methods and Results A prospective registry of consecutive patients with severe aortic stenosis at 23 centers in 9 European countries with transcatheter as well as surgical aortic valve replacement being available was performed. The study included a 3-month documentation of the status quo (phase A), a 6-month intervention phase (implementing facilitated data relay), and a 3-month documentation of a legacy effect (phase-B). Two thousand one hundred seventy-one patients with severe aortic stenoses were enrolled (phase A: 759; intervention: 905; phase-B: 507). Mean age was 77.9±10.0 years, and 80% were symptomatic, including 52% with severe symptoms. During phase A, intervention was planned in 464/696 (67%), 138 (20%) were assigned to watchful waiting, 8 (1%) to balloon aortic valvuloplasty, 60 (9%) were listed as not for active treatment, and in 26 (4%), no decision was made. Three hundred sixty-three of 464 (78%) patients received the planned intervention within 3 months. Timeliness of the intervention improved as shown by the higher number of aortic valve replacements performed within 3 months (59% versus 51%, P=0.002) and a significant decrease in the time to intervention (36±38 versus 30±33 days, P=0.002). Conclusions A simple, low-cost, facilitated data relay improves timeliness of treatment for patients diagnosed with severe aortic stenosis, resulting in a shorter time to transcatheter aortic valve replacement. This effect was mainly driven by a significant improvement in timeliness of intervention in transcatheter aortic valve replacement but not surgical aortic valve replacement. Clinical Trial Registration URL: https://www.clinicaltrials.gov/. Unique identifier: NCT02241447.

See more in PubMed

Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. The Tromso study. Heart. 2013;99:396–400. PubMed

Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Munoz D, Rosenhek R, Sjogren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–2791. PubMed

Otto CM, Kumbhani DJ, Alexander KP, Calhoon JH, Desai MY, Kaul S, Lee JC, Ruiz CE, Vassileva CM. 2017 ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2017;69:1313–1346. PubMed

Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron‐Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Lung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio‐Thoracic Surgery (EACTS). Eur J Cardiothorac Surg. 2012;42:S1–S44. PubMed

Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP III, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM III, Thomas JD, Members AATF. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:e521–e643. PubMed

Iung B, Baron G, Butchart EG, Delahaye F, Gohlke‐Barwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24:1231–1243. PubMed

Freed BH, Sugeng L, Furlong K, Mor‐Avi V, Raman J, Jeevanandam V, Lang RM. Reasons for nonadherence to guidelines for aortic valve replacement in patients with severe aortic stenosis and potential solutions. Am J Cardiol. 2010;105:1339–1342. PubMed

Heuvelman HJ, van Geldorp MW, Kappetein AP, Geleijnse ML, Galema TW, Bogers AJ, Takkenberg JJ. Clinical course of patients diagnosed with severe aortic stenosis in the Rotterdam area: insights from the AVARIJN study. Neth Heart J. 2012;20:487–493. PubMed PMC

Chan RH, Shaw JL, Hauser TH, Markson LJ, Manning WJ. Guideline adherence for echocardiographic follow‐up in outpatients with at least moderate valvular disease. J Am Soc Echocardiogr. 2015;28:795–801. PubMed

Ahmed A, Sorajja P, Garberich RF, Farivar RS, Harris KM, Gossl M. Association of guideline adherence for serial evaluations with survival and adverse clinical events in patients with asymptomatic severe aortic stenosis. JAMA Cardiol. 2017;2:1141–1146. PubMed PMC

Malaisrie SC, McDonald E, Kruse J, Li Z, McGee EC Jr, Abicht TO, Russell H, McCarthy PM, Andrei AC. Mortality while waiting for aortic valve replacement. Ann Thorac Surg. 2014;98:1564–1570; discussion 1570–1561. PubMed

Lund O, Nielsen TT, Emmertsen K, Flo C, Rasmussen B, Jensen FT, Pilegaard HK, Kristensen LH, Hansen OK. Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. Thorac Cardiovasc Surg. 1996;44:289–295. PubMed

Dziadzko V, Clavel MA, Dziadzko M, Medina‐Inojosa JR, Michelena H, Maalouf J, Nkomo V, Thapa P, Enriquez‐Sarano M. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018;391:960–969. PubMed PMC

Frey N, Steeds RP, Serra A, Schulz E, Baldus S, Lutz M, Pohlmann C, Kurucova J, Bramlage P, Messika‐Zeitoun D. Quality of care assessment and improvement in aortic stenosis—rationale and design of a multicentre registry (IMPULSE). BMC Cardiovasc Disord. 2017;17:5. PubMed PMC

Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30:372–392. PubMed

Katz S, Downs TD, Cash HR, Grotz RC. Progress in development of the index of ADL. Gerontologist. 1970;10:20–30. PubMed

Iung B, Messika‐Zeitoun D, Cachier A, Delahaye F, Baron G, Tornos P, Gohlke‐Barwolf C, Boersma E, Ravaud P, Vahanian A. Actual management of patients with asymptomatic aortic valve disease: how practice fits with guidelines. Am Heart J. 2007;153:696–703. PubMed

Schwarz F, Baumann P, Manthey J, Hoffmann M, Schuler G, Mehmel HC, Schmitz W, Kubler W. The effect of aortic valve replacement on survival. Circulation. 1982;66:1105–1110. PubMed

Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J. 1988;9(Suppl E):57–64. PubMed

Rosenhek R, Zilberszac R, Schemper M, Czerny M, Mundigler G, Graf S, Bergler‐Klein J, Grimm M, Gabriel H, Maurer G. Natural history of very severe aortic stenosis. Circulation. 2010;121:151–156. PubMed

Lancellotti P, Rosenhek R, Pibarot P, Iung B, Otto CM, Tornos P, Donal E, Prendergast B, Magne J, La Canna G, Pierard LA, Maurer G. ESC Working Group on Valvular Heart Disease position paper–heart valve clinics: organization, structure, and experiences. Eur Heart J. 2013;34:1597–1606. PubMed

Chambers JB, Ray S, Prendergast B, Taggart D, Westaby S, Grothier L, Arden C, Wilson J, Campbell B, Sandoe J, Gohlke‐Barwolf C, Mestres CA, Rosenhek R, Otto C. Specialist valve clinics: recommendations from the British Heart Valve Society working group on improving quality in the delivery of care for patients with heart valve disease. Heart. 2013;99:1714–1716. PubMed

Zilberszac R, Lancellotti P, Gilon D, Gabriel H, Schemper M, Maurer G, Massetti M, Rosenhek R. Role of a heart valve clinic programme in the management of patients with aortic stenosis. Eur Heart J Cardiovasc Imaging. 2017;18:138–144. PubMed

Taggu W, Topham A, Hart L, Carr‐White G, Sulke N, Patel NR, Lloyd G. A cardiac sonographer led follow up clinic for heart valve disease. Int J Cardiol. 2009;132:240–243. PubMed

Shojania KG, Ranji SR, Shaw LK, Charo LN, Lai JC, Rushakoff RJ, McDonald KM, Owens DK. Closing the Quality Gap: A Critical Analysis of Quality Improvement Strategies (Vol. 1: series overview and methodology). Rockville, MD: Agency for Healthcare Research and Quality (US); 2004. Available at: https://www.ncbi.nlm.nih.gov/books/NBK43908/. PubMed

Walsh JM, McDonald KM, Shojania KG, Sundaram V, Nayak S, Lewis R, Owens DK, Goldstein MK. Quality improvement strategies for hypertension management: a systematic review. Med Care. 2006;44:646–657. PubMed

Wijeysundera HC, Wong WW, Bennell MC, Fremes SE, Radhakrishnan S, Peterson M, Ko DT. Impact of wait times on the effectiveness of transcatheter aortic valve replacement in severe aortic valve disease: a discrete event simulation model. Can J Cardiol. 2014;30:1162–1169. PubMed

See more in PubMed

ClinicalTrials.gov
NCT02241447

Find record

Citation metrics

Archiving options